BIOX · Bioceres Crop Solutions Corp. · Insider Trading
$0.21
-0.02 (-9.77%)
At close · Oct 28
Return incl. dividend (before tax)
Q4 2026 earnings call transcript
Market Cap
$15.15M
Shares
63.82M
Volume · Oct 28
378.84K
Avg daily vol (3M)
306.77K
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-03 | Simmermacher Ezequiel |
CFO |
Award↑
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
These options were granted on August 3, 2026, pursuant to the terms of a stock option agreement under the 2023 Omnibus Equity Incentive Plan. The options vest annually in three equal installments commencing June 30, 2026, subject to vesting conditions. |
Employee Stock Option (Right to Buy)
|
375,000 |
| 2026-05-20 | Trucco Federico |
Director, CEO |
Gift↓
Filing footnotes — Ordinary Shares (Indirect)
These securities are held by Testamentario MQT Trust, for the benefit of the Reporting Person's child. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |
Ordinary Shares
(I)
|
130,000 |
Legend
Buy — open-market purchase
Sell — open-market sale
↑ Shares acquired
↓ Shares disposed (gift, conversion, tax…)
Showing 1–2 of 2 transactions